Young age alone does not warrant mastectomy after neoadjuvant systemic therapy.
In a multi-institutional analysis (including our very own @tchou_julia) out of 1,737 patients in the I-SPY2.0 trial, women ≤45 underwent breast-conserving surgery less often than older women, yet
PENN SURGERY is dedicated to high quality patient care, education, basic science and clinical research. #upenn #pennsurgery #PennProud
- A recent “Invited Commentary” in the newest issue of @JVascSurg by Chief, Vascular Surgery and Endovascular Therapy, Penn Presbyterian Medical Center, Shang Loh, MD, says the results show promising progress for challenging AAA anatomy: the Gore Conformable Excluder shows improved
- Ready to advance your career in surgical oncology research? Join the Penn T32 Surgical Oncology Research Training Program and gain the mentorship, research experience, and professional development needed to become a leader in academic surgery. bit.ly/4g6Gm1p
- Could we better identify patients at risk for primary aldosteronism? In an independent cohort of 652 patients screened for PA, 13% tested positive. A novel risk score showed a clear stepwise increase in PA prevalence, with an optimal cut-point of 6 and AUC 0.66. A promising tool
- A standardized care pathway for adrenal incidentalomas, including structured radiology reporting, EHR order sets, and a dedicated adrenal clinic boosted biochemical evaluation to 90% and identified hormonally active disease in 20% of patients, improving detection of surgically

